Holen Sie sich die Stockscreener-App
2.19
0.45%
-0.01
Schlusskurs vom Vortag:
$2.20
Offen:
$2.2
24-Stunden-Volumen:
25,234
Relative Volume:
0.63
Marktkapitalisierung:
$66.77M
Einnahmen:
$300.00K
Nettoeinkommen (Verlust:
$-40.16M
KGV:
-1.6624
EPS:
-1.3174
Netto-Cashflow:
$-42.36M
1W Leistung:
+0.92%
1M Leistung:
+0.00%
6M Leistung:
-6.81%
1J Leistung:
-17.05%
1-Tages-Spanne:
$2.19
$2.20
1-Wochen-Bereich:
$2.13
$2.21
52-Wochen-Spanne:
$2.09
$3.44
Xbiotech Inc Stock (XBIT) Company Profile
Firmenname
Xbiotech Inc
Sektor
Branche
Telefon
512-386-2900
Adresse
5217 WINNEBAGO LANE, AUSTIN, TX
Compare XBIT vs VRTX, MRNA, REGN, ARGX, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XBIT
Xbiotech Inc
|
2.19 | 66.16M | 300.00K | -40.16M | -42.36M | -1.3174 |
VRTX
Vertex Pharmaceuticals Inc
|
504.73 | 133.37B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
190.01 | 79.40B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
735.20 | 81.13B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
919.21 | 60.03B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
206.64 | 43.93B | 742.00K | -1.37B | -1.07B | -7.0731 |
Xbiotech Inc Stock (XBIT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2019-06-14 | Eingeleitet | Piper Jaffray | Overweight |
| 2017-04-21 | Herabstufung | Noble Financial | Buy → Hold |
| 2016-06-28 | Bestätigt | Noble Financial | Buy |
Xbiotech Inc Aktie (XBIT) Neueste Nachrichten
Xbiotech Stock Price Forecast. Should You Buy XBIT? - StockInvest.us
XBiotech (NASDAQ:XBIT) Shares Cross Below 200-Day Moving AverageTime to Sell? - marketbeat.com
XBiotech (XBIT) Slips 4.78% to $2.19, Testing Key Support at $2.08Supply Zone - vinanet.vn
XBiotech (NASDAQ:XBIT) Share Price Passes Above 50 Day Moving AverageHere's What Happened - MarketBeat
XBiotech (XBIT) Quarter in Focus: Reported EPS Misses Expectations for This Review; Closing Move - vinanet.vn
XBiotech (XBIT) Move: Advances 0.22% to $2.30 for the Current Session; Current Setup: Price Remains Between $2.18 Support and $2.42 Resistance at the CloseEarly Entry Signals - vinanet.vn
XBiotech (XBIT) Quarter in Focus: Reported EPS Misses Expectations for This Review; Closing Move: The Market Price Advances 0.65% at the CloseProfitability Analysis - dars.gov.et
XBiotech (NASDAQ:XBIT) Issues Quarterly Earnings Results, Misses Estimates By $0.25 EPS - MarketBeat
XBiotech: Q2 Earnings Snapshot - AOL.com
XBiotech (NASDAQ: XBIT) trims R&D spend yet remains loss-making in Q2 2026 - Stock Titan
XBiotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
XBiotech (XBIT) Earnings Date and Reports 2026 $XBIT - MarketBeat
XBiotech (XBIT) Edges Higher at $2.28 as Stock Consolidates Between Key Support and ResistanceJelly Roll Trade - dars.gov.et
XBiotech Inc (XBIT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
XBiotech Inc (XBIT) Stock News Today - TradingKey
XBiotech (NASDAQ:XBIT) Share Price Crosses Below 200-Day Moving AverageWhat's Next? - MarketBeat
XBiotech Inc (XBIT) Income Statement - TradingKey
XBiotech Inc (XBIT) Institutional Confidence - TradingKey
XBiotech Inc (XBIT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
XBiotech Inc (XBIT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
XBiotech Inc (XBIT) Balance Sheet - TradingKey
XBIT|XBiotech Inc|Price:2.300|Chg%:+0.030 - TradingKey
XBiotech Inc (XBIT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
XBiotech Inc (XBIT) Cash Flow - TradingKey
XBiotech Inc (XBIT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
XBiotech Inc (XBIT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
XBIT|XBiotech Inc|Price:2.270| - TradingKey
XBiotech, Inc. Actuals & Estimates (FWB:4XB) - TradingView
XBiotech Inc. Revenue Breakdown – NASDAQ:XBIT - TradingView
XBIT|XBiotech Inc|Price:2.270|Chg%:-0.010 - TradingKey
XBiotech Inc. (XBIT) Slips Slightly, Holds Above Key SupportTriple MA Cross - dars.gov.et
MSN Money - MSN
XBiotech (XBIT) Holds Steady at $2.29 as Range-Bound Trading ContinuesIPO Entry Watch - dars.gov.et
XBiotech Inc. (XBIT) Slides 2.97% as Shares Approach Key Support at $2.18Pairs Trade - dars.gov.et
XBiotech focuses on antibody pipeline as biotech sector evolves - Ad-hoc-news.de
ETFs Investing in XBiotech, Inc. Stocks - TradingView
XBiotech, Inc. Actuals & Estimates (SWB:4XB) - TradingView
XBiotech Inc. (XBIT) Holds Steady at $2.33 as Key Support and Resistance Levels ConvergeVolume Dry Up - dars.gov.et
XBiotech, Inc. Actuals & Estimates (LS:A14QF1) - TradingView
XBiotech, Inc. Actuals & Estimates (MUN:4XB) - TradingView
Price to earnings forward of XBiotech Inc. – NASDAQ:XBIT - TradingView
XBiotech, Inc. Actuals & Estimates (NASDAQ:XBIT) - TradingView
Price to sales forward of XBiotech Inc. – NASDAQ:XBIT - TradingView
XBiotech, Inc. Actuals & Estimates (DUS:4XB) - TradingView
XBiotech, Inc. Actuals & Estimates (BX:4XB) - TradingView
Enterprise value to revenue forward of XBiotech Inc. – NASDAQ:XBIT - TradingView
XBiotech, Inc. Actuals & Estimates (BOATS:XBIT) - TradingView
Price to book forward of XBiotech Inc. – NASDAQ:XBIT - TradingView
Enterprise value to EBIT forward of XBiotech Inc. – NASDAQ:XBIT - TradingView
XBiotech to commence V-SPINE trial enrolment for vilamakitug - MSN
XBiotech (XBIT) Dips 2.53% as Shares Test Support Near $2.19Covered Call Trade - dars.gov.et
Finanzdaten der Xbiotech Inc-Aktie (XBIT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.05%
0.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):